Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding

Endometrial Disorder Clinical Trial

Official title:

Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03351673
• Other study ID #: Endometrial volume
• Status: Recruiting
• Phase: N/A
• First received: November 20, 2017
• Last updated: November 22, 2017
• Start date: August 8, 2017
• Est. completion date: August 2018

Study information

• Verified date: November 2017
• Source: Mansoura University
• Contact: Hanan Nabil, MD
• Phone: 002/01000571004
• Email: hanannobil00[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Endometrial thickness has been used as an indicator of risk for endometrial hyperplasia and carcinoma in asymptomatic perimenopausal women. However, there is no cutoff value in perimenopausal women and the same thickness does not express the same endometrial volume in different endometrium because uterine lengths may be different and endometrial irregularities may exist. Many studies assessed endometrial volume measured by three-dimensional (3D) TVS as a predictor of malignancy in women with postmenopausal bleeding. To our knowledge there is no study assess endometrial volume measured by two dimension TVS in prediction of endometrial pathology, however it is cheap and available than 3D TVS.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: August 2018
• Est. primary completion date: August 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 45 Years to 55 Years

Eligibility

Inclusion Criteria:

*perimenopausal women with abnormal bleeding e.g. menorrhagia, metrorrhagia and polymenorrhea.

Exclusion Criteria:

*general or local causes of bleeding, drug intake or recent hormonal contraception

Related Conditions & MeSH terms

• Endometrial Disorder
• Hemorrhage
• Uterine Hemorrhage

Intervention

Diagnostic Test:
• endometrial volume 2D TVS
calculation the endometrial volume using 2D ultrasound and correlation the results with the pathological findings of endometrial biopsy

Locations

Country	Name	City	State
Egypt	mansoura University	Mansourah	Dakahlia

Sponsors (1)

Lead Sponsor	Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	accuracy of measurement of endometrial volume by 2D TVS in prediction of endometrial pathology		1year